IGS

TRC showcases end-to-end solutions for the energy transition at DISTRIBUTECH 2024

Retrieved on: 
Wednesday, February 21, 2024

WINDSOR, Conn., Feb. 21, 2024 /PRNewswire-PRWeb/ -- TRC Companies, Inc. (TRC), a global professional services firm providing integrated strategy, consulting, engineering and applied technologies in support of the Energy Transition, is exhibiting at DISTRIBUTECH International 2024, the world's largest event for the transmission and distribution industry. DISTRIBUTECH will take place Feb. 26 to Feb. 29, 2024, in Orlando.

Key Points: 
  • WINDSOR, Conn., Feb. 21, 2024 /PRNewswire-PRWeb/ -- TRC Companies, Inc. (TRC), a global professional services firm providing integrated strategy, consulting, engineering and applied technologies in support of the Energy Transition, is exhibiting at DISTRIBUTECH International 2024, the world's largest event for the transmission and distribution industry.
  • DISTRIBUTECH will take place Feb. 26 to Feb. 29, 2024, in Orlando.
  • "TRC creates breakthrough solutions that navigate and adapt to complex industry changes while delivering safe, reliable service to customers," says Ed Myszka, President of TRC's Power Sector.
  • TRC is unveiling its refreshed brand with a focus on how the company is #PoweringTheShift to deliver agility, fortitude and peace-of-mind to utilities addressing the energy transition and changing landscapes.

T.H.R.I.V.E. Emerging Leaders Reimagined Program Opens Applications for the 2024 Cohort

Retrieved on: 
Wednesday, February 21, 2024

WASHINGTON, Feb. 21, 2024 /PRNewswire/ -- Small business owners looking for professional development need look no further than SBA's T.H.R.I.V.E. Emerging Leaders Reimagined Program. This transformative initiative offers small business owners across the United States a unique opportunity to accelerate their business growth through an intensive, executive-level training program.

Key Points: 
  • Emerging Leaders Reimagined Program.
  • This transformative initiative offers small business owners across the United States a unique opportunity to accelerate their business growth through an intensive, executive-level training program.
  • The program combines online learning with in-person sessions, focusing on leadership enhancement, strategic financial management, market innovation, and cultivating a thriving company culture.
  • Emerging Leaders Reimagined to a peer, and 92% gained additional knowledge and insights from the curriculum.

Med-Surgical Services, Inc. Launches Next-Generation CBYON Eclipse Navigation System

Retrieved on: 
Thursday, February 15, 2024

This next-generation IGS technology platform includes:

Key Points: 
  • This next-generation IGS technology platform includes:
    Automatic image registration: seamless registration of patient data acquired through intraoperative 3D X-ray imaging devices.
  • The CBYON Eclipse system has been used in over 1,000 procedures since its release in June 2022.
  • Its design allows affordable, agnostic, and highly accurate support for the vast majority of surgeries, from routine to complex.
  • “The CBYON technology continues to evolve and improve to better support IGS procedures in a number of settings,” said Rory Randall, CEO/CTO of MSSI.

Informed XP and Cadmus Announce SBA Mentor-Protégé Joint Venture

Retrieved on: 
Tuesday, January 23, 2024

WASHINGTON, Jan. 23, 2024 /PRNewswire/ -- Informed XP announced it has joined Cadmus, a strategic and technical consultancy, in a Joint Venture (JV) and Mentor-Protégé Agreement (MPA) under the Small Business Administration (SBA) Mentor-Protégé Program (MPP), as Informed Government Solutions (IGS).

Key Points: 
  • Informed Government Solutions (IGS) is the partnership between CTW Solutions LLC, dba Informed XP, and Cadmus, providing transformative, human-centered solutions to federal agencies.
  • WASHINGTON, Jan. 23, 2024 /PRNewswire/ -- Informed XP announced it has joined Cadmus , a strategic and technical consultancy, in a Joint Venture (JV) and Mentor-Protégé Agreement (MPA) under the Small Business Administration (SBA) Mentor-Protégé Program (MPP), as Informed Government Solutions (IGS) .
  • "Informed XP has a wealth of experience in crafting human-centered solutions in the commercial space, and we are thrilled to further leverage those insights and honed practices in the government space in an impactful way," said Tina Williams, founder and CEO of Informed XP.
  • For more information about IGS, contact Chris Williams, principal at Informed XP, at [email protected] .

Med-Surgical Services, Inc. Hits CBYON Sales Milestone on Heels of $4 Million Series A Financing Round

Retrieved on: 
Tuesday, January 16, 2024

This sales milestone comes on the heels of successfully completing a $3.9 million Series A funding round led by Core Guidance LLC, a medical technology-focused investment fund.

Key Points: 
  • This sales milestone comes on the heels of successfully completing a $3.9 million Series A funding round led by Core Guidance LLC, a medical technology-focused investment fund.
  • IGS improves the safety and efficiency of surgeries while allowing surgeons to navigate with unprecedented accuracy.
  • The CBYON Eclipse System is an image-guided surgical system that supports cranial, spine, and ENT procedures.
  • “Achieving this notable sales milestone in our first year of commercial operations is a feat that we are exceedingly proud of,” commented Brian Moore, Managing Director of Core Guidance.

“GigaFarm” capable of replacing 1% of UAE food imports set for construction in Dubai Food Tech Valley

Retrieved on: 
Wednesday, December 6, 2023

DUBAI, United Arab Emirates, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Food Tech Valley has signed an agreement at COP28 with ReFarmTM to start construction on a 900,000 sq. ft. game-changing “GigaFarm”. The innovative waste-to-value farm will be capable of recycling more than 50,000 tonnes of food waste and growing two billion plants each year.

Key Points: 
  • DUBAI, United Arab Emirates, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Food Tech Valley has signed an agreement at COP28 with ReFarmTM to start construction on a 900,000 sq.
  • The innovative waste-to-value farm will be capable of recycling more than 50,000 tonnes of food waste and growing two billion plants each year.
  • Capable of growing more than three million kilos of produce annually, the site will support the UAE’s move towards decarbonising food production, replacing 1% of the country’s fresh produce imports.
  • Construction is due to begin in mid-2024, with the site expected to be fully operational by 2026.

Takeda Receives Positive CHMP Opinion for HYQVIA® as Maintenance Therapy in Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Retrieved on: 
Friday, December 15, 2023

Takeda ( TSE:4502/NYSE:TAK ) today announced the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of HYQVIA® [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) as maintenance therapy after stabilization with intravenous immunoglobulin therapy (IVIG).

Key Points: 
  • Takeda ( TSE:4502/NYSE:TAK ) today announced the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of HYQVIA® [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) as maintenance therapy after stabilization with intravenous immunoglobulin therapy (IVIG).
  • The European Commission (EC) will consider the CHMP positive opinion when determining the potential marketing authorization for HYQVIA for CIDP throughout the European Union.
  • This proposed extension of indication for HYQVIA is based on data from the pivotal Phase 3 ADVANCE-CIDP 1 clinical trial, which investigated HYQVIA as maintenance therapy in adult patients with CIDP.
  • HYQVIA is also under regulatory review in the United States for use as a maintenance therapy in adult patients with CIDP.

GE HealthCare Showcases More Than 40 Innovations, Including AI-Enabled Imaging Technology Solutions Designed for Precision Care at RSNA23

Retrieved on: 
Sunday, November 26, 2023

Each connected care solution is designed to better support clinicians, improve patient care, and increase health system efficiency at a time when healthcare system challenges include rising levels of radiologist burnout and shortages.

Key Points: 
  • Each connected care solution is designed to better support clinicians, improve patient care, and increase health system efficiency at a time when healthcare system challenges include rising levels of radiologist burnout and shortages.
  • By using GE HealthCare integrated technologies and diagnostics, clinicians deliver a more personal, precise, and human-focused approach across the care continuum.
  • GE HealthCare is exploring, along with clinical collaborators, how AI can help predict patient response to immunotherapies.
  • For more information on GE HealthCare and these innovative solutions at RSNA, visit Booth 7326, our press kit , or the RSNA 2023 events page .

Ad Astra Diagnostics receives 510(k) clearance of QScout™ hematology analyzer, the first to report measures of infection and severity at point-of-care

Retrieved on: 
Thursday, December 7, 2023

MORRISVILLE, N.C., Dec. 7, 2023 /PRNewswire/ -- Ad Astra Diagnostics (AAD), developer of rapid diagnostic systems, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its QScout™ rapid-result hematology system, which provides fast, point-of-care white blood cell counts (WBCs), neutrophil-to-lymphocyte ratio, and differentiates the number and percent of five types of mature WBCs as well as immature granulocytes.

Key Points: 
  • QScout™ is the first hematology platform designed for simple, fast operation at the point-of-care.
  • It provides lab-grade, patient-side results that caregivers use to screen for health conditions including infection, leukemia, and other blood-related cancers, allergies, and many more.
  • Elevated levels of IGs have been shown to differentiate sepsis earlier than commonly used measures like lactate and procalcitonin1.
  • Additionally, NLR is an increasingly important predictor of poor health outcomes that gained greater use during the pandemic.

Ad Astra Diagnostics receives 510(k) clearance of QScout™ hematology analyzer, the first to report measures of infection and severity at point-of-care

Retrieved on: 
Thursday, November 16, 2023

MORRISVILLE, N.C., Nov. 16, 2023 /PRNewswire/ -- Ad Astra Diagnostics (AAD), developer of rapid diagnostic systems, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its QScout™ rapid-result hematology system, which provides fast, point-of-care white blood cell counts (WBCs), neutrophil-to-lymphocyte ratio, and differentiates the number and percent of five types of mature WBCs as well as immature granulocytes.

Key Points: 
  • QScout™ is the first hematology platform designed for simple, fast operation at the point-of-care.
  • It provides lab-grade, patient-side results to screen for health conditions including infection, leukemia and other blood-related cancers, allergies, and many more.
  • Additionally, NLR is an increasingly important predictor of poor health outcomes, which gained greater use during the pandemic.
  • Sepsis, the body's extreme response to infection, is a life-threatening medical emergency that happens when infection triggers a chain reaction throughout the body.